在FAERS数据库中的olanzapine不良事件的信号挖掘和风险分析
Aiguo Dong1, Lingyi Shi1, Zhiqiang Du1
1Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
|November 17, 2024
概括
这项研究分析了FAERS数据库中的olanzapine不良事件 (AE). 确定了新的心血管风险,包括胰腺炎和心肌再注射损伤,需要进一步调查.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 奥兰沙平是一种用于治疗精神疾病的抗精神病药物.
- 通过不良事件 (AE) 分析评估olanzapine的安全性,这对于患者的安全至关重要.
- 识别与olanzapine使用相关的新出现的风险对于更新临床指南至关重要.
研究的目的:
- 通过分析FDA不良事件报告系统 (FAERS) 数据库中报告的不良事件 (AE) 来评估olanzapine的安全性.
- 识别和描述与olanzapine相关的新安全信号和以前未知的风险.
- 通过使用已建立的信号挖掘方法来评估确定不良事件的频率和强度.
主要方法:
- 利用FAERS数据库对2004年1月1日至2023年6月30日的olanzapine相关不良事件进行了分析.
- 采用了四种信号挖掘方法:报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信任传播神经网络 (BCPNN) 和实证贝叶斯几何平均值 (EBGM).
- 分析了43,664份报告,其中奥兰扎宾是主要的可疑药物,在27个系统器官类 (SOC) 中识别了776个首选术语 (PT) 信号.
主要成果:
- 确定了Olanzapine的776个显著不良事件信号,其中精神病和神经系统疾病是最常见的.
- 主要受影响的人口群体包括女性和年龄在18-45岁之间的个人.
- 新发现的潜在风险包括心血管事件,如胰腺炎,基洛米克隆增加,高基洛米克隆血症和心肌再流损伤,以及罕见但严重的事件,如神经乱性恶性综合征和无意识症.
结论:
- 药监测分析发现了与olanzapine相关的新型心血管风险,特别是胰腺炎和心肌再注射损伤.
- 这些新发现的风险需要进一步严格调查,以确认因果关系并了解它们的临床意义.
- 这些发现强调了对抗精神病药物如olanzapine的持续安全监测的重要性.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
455
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
01:24Mania and Antimanic Drugs: Overview
136
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
136
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121